USPTO serial 88059275
COLORDOME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 5, 2020
- Examiner
- WOLFE, YOUNG J
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with COLORDOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Margaret M. Carley
Margaret M. Carley PANDISCIO & PANDISCIO83 Walnut StreetSuite 150Wellesley, MA 02481Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Laboratory apparatus and equipment, namely, visual electrophysiology equipment for rodent electroretinography testing for research purposes, and components and peripherals in the nature of rodent platforms in the nature of platforms for stabilizing rodents during electroretinography testing, illuminating laboratory lamps, electrodes, pattern stimulators for generating optical test patterns for presentation to a test subject, amplifiers, computers and infrared cameras, and software for interpreting, storing and exporting data all sold as a unit; software for use with visual electrophysiology equipment, for interpreting, storing and exporting data sold as an integral component of laboratory apparatus and equipment, namely, visual electrophysiology equipment for rodent electroretinography testing for research purposes; software for use with visual electrophysiology equipment, for interpretation of data related to diagnosing ophthalmic conditions, vision research, drug trials and evaluation of retinal function; software for use with visual electrophysiology equipment, for interpretation of data related to rodent electroretinography testing for research purposes; visual electrophysiology equipment in the nature of apparatus for testing vision, computers, cameras, computer monitors, pattern stimulators for generating optical test patterns for presentation to a test subject, amplifiers, Ganzfeld stimulators and Ganzfeld domes for vision research; visual electrophysiology equipment in the nature of apparatus for testing vision, Ganzfeld stimulators, Ganzfeld domes, computer monitors, amplifiers, wheeled carts and stands for use in clinical drug trials specially adapted for visual electrophysiology laboratory equipment, laboratory apparatus and equipment, namely, visual electrophysiology equipment for rodent electroretinography testing for research purposes, and components and peripherals in the nature of rodent platforms in the nature of platforms for stabilizing rodents during electroretinography testing, illuminating laboratory lamps, electrodes, pattern stimulators for generating optical test patterns for presentation to a test subject, amplifiers, computers and infrared cameras | ACTIVE | Dec 31, 2001 |
| 010 | medical apparatus and equipment, namely, visual electrophysiology equipment for use in diagnosing ophthalmic conditions and evaluation of retinal function, and components and peripherals in the nature of computers, cameras, pattern stimulators for generating optical test patterns for presentation to a test subject, Ganzfeld stimulators, Ganzfeld domes, desktop and operating room mounting arms for computer monitors, amplifiers, cables, electrical connectors, computer monitors, conductive gels and pastes, light filters, and software for interpreting, storing and exporting data all sold as a unit; software for interpreting, storing and exporting data sold as an integral component of medical apparatus and equipment, namely, visual electrophysiology equipment for use in diagnosing ophthalmic conditions and evaluation of retinal function | ACTIVE | Dec 31, 2001 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 10, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 10, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 9, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 5, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 5, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 18, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 18, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 16, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 11, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 11, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 9, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 10, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 10, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 10, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 11, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 11, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 7, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jun 3, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 3, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Dec 3, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Dec 3, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 16, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 6, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |